Skip to content

Intraosseous Access in the Emergency Department for Patients With Failed Attempts at Intravenous Access: A Randomized Trial Examining Resource Utilization and Patient Satisfaction

Intraosseous Access in the Emergency Department for Patients With Failed Attempts at Intravenous Access: A Randomized Trial Examining Resource Utilization and Patient Satisfaction

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01676350
Enrollment
22
Registered
2012-08-30
Start date
2014-08-31
Completion date
2015-06-30
Last updated
2022-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Difficult Peripheral IV Access

Keywords

Intraosseous (IO) vascular access

Brief summary

By doing this study, the investigators hope to learn whether patients with difficult to obtain IV access who are treated with IO access are more satisfied with their care and have better outcomes. The investigators are specifically studying the time difference between groups and the difference in the number of attempts required to obtain vascular access and begin to treat with fluids and medications. The study will also measure patient satisfaction and procedural pain, the frequency of central line placement, the length of stay in the hospital and emergency department, and adverse events to intravascular access to determine whether IO access can improve these measures. The investigators hypothesize that the use of a protocol utilizing an IO device for select patients with failed IV access will reduce the time requirements to obtain vascular access, reduce the number of attempts needed to obtain IV access, reduce the ED LOS, and have no negative impact on patient satisfaction compared to the current ED practices.

Interventions

PROCEDUREIO access using EZ-IO®

IO line placed using an FDA-approved device called an EZ-IO®.

Sponsors

University of Pennsylvania
CollaboratorOTHER
WellSpan Health
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. 18 years of age or older 2. Hemodynamically stable 3. Speaks English 4. Able to consent 5. Has difficult IV access

Exclusion criteria

1\. Patients who are younger than 18 years of age, b) lack English fluency c) are unable to give informed consent d) require immediate central venous access e) have a history of osteomyelitis in the only target location of IO access f) have a fracture in the bone of the only target IO site g) have received an IO in the last 24 hours of the only target site h) are allergic to lidocaine i) pregnant or j) require a contrast CT scan as part of their ED care will be excluded. While pregnant patients may benefit from rescue access the use of lidocaine to anesthetize the medullary space has not been studied in this population.

Design outcomes

Primary

MeasureTime frame
Time to Successful Placement of a Functioning USGIV/IOat time of vascular access
Number of Successful Placementsat time of vascular access

Countries

United States

Participant flow

Participants by arm

ArmCount
Standard of Care
Standard of care
11
IO Access
IO access
11
Total22

Baseline characteristics

CharacteristicStandard of CareIO AccessTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
2 Participants1 Participants3 Participants
Age, Categorical
Between 18 and 65 years
9 Participants10 Participants19 Participants
Sex: Female, Male
Female
7 Participants8 Participants15 Participants
Sex: Female, Male
Male
4 Participants3 Participants7 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 110 / 11
other
Total, other adverse events
0 / 110 / 11
serious
Total, serious adverse events
0 / 110 / 11

Outcome results

Primary

Number of Successful Placements

Time frame: at time of vascular access

ArmMeasureValue (NUMBER)
Standard of CareNumber of Successful Placements11 successful placements
&Apos;IO Access Using EZ-IO®Number of Successful Placements8 successful placements
Primary

Time to Successful Placement of a Functioning USGIV/IO

Time frame: at time of vascular access

ArmMeasureValue (MEAN)Dispersion
Standard of CareTime to Successful Placement of a Functioning USGIV/IO163.7 secondsStandard Deviation 177.9
&Apos;IO Access Using EZ-IO®Time to Successful Placement of a Functioning USGIV/IO67.3 secondsStandard Deviation 98.5

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026